share_log

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SBLENDORIO GLENN

SEC ·  Jun 7 19:47
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more